VALEANT PHARMS INTL
SpecialtyVALEANT PHARMS INTL is a specialty pharmaceutical company focused on Immunology, Gastroenterology. Key products include GIAZO.
VALEANT PHARMS INTL's Key Drugs
VALEANT PHARMS INTL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
VALEANT PHARMS INTL's Recent FDA Approvals
New NDA/BLA approvals for VALEANT PHARMS INTL over the last two years — novel drugs only, excluding generics and label supplements.
VALEANT PHARMS INTL's Therapeutic Areas
VALEANT PHARMS INTL's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Gastroenterology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
VALEANT PHARMS INTL's Top Competitors
VALEANT PHARMS INTL's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
VALEANT PHARMS INTL Pipeline Snapshot
Active clinical trials for VALEANT PHARMS INTL across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 1970-12-04
- Latest
- 2023-10-24
- Applications
- 3